{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:49Z","timestamp":1753892029558,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The promoting effect of the regulator of calcineurin 2 (RCAN2) in hepatic steatosis has been observed in animal studies. However, the association of RCAN2 with non-alcoholic fatty liver disease (NAFLD) in humans remains unclear. This study aimed to evaluate the expression of RCAN2 in the liver of mice with hepatic steatosis and in the serum of NAFLD patients and to explore the relationship between serum RCAN2 levels and NAFLD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The mRNA and protein expression of RCAN2 were detected by quantitative real-time PCR (qRT-PCR) and Western blot. NAFLD was diagnosed by abdominal ultrasonography. Circulating RCAN2 levels were measured by ELISA kits. The relationship between serum RCAN2 levels and NAFLD was assessed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> qRT-PCR and Western blot analysis showed that compared with the corresponding controls, the mRNA and protein expression of RCAN2 were significantly increased in the liver tissues of db\/db and mice on a high-fat diet. Serum RCAN2 levels were markedly elevated in NAFLD patients compared with non-NAFLD subjects. Binary logistic regression analysis showed that serum RCAN2 levels were significantly associated with NAFLD. Receiver operation characteristic (ROC) curve analysis showed that serum RCAN2 might act as a predictive biomarker for NAFLD [area under the curve (AUC) = 0.663, 95% CI = 0.623\u20130.702], and the serum RCAN2\/(AST\/ALT) ratio displayed improved predictive accuracy (AUC = 0.816, 95% CI = 0.785\u20130.846).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Elevated serum RCAN2 levels were associated with an increased risk of NAFLD. Serum RCAN2, especially the serum RCAN2\/(AST\/ALT) ratio, might be a candidate diagnostic marker for NAFLD.<\/jats:p>","DOI":"10.3389\/fphar.2022.840764","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T10:24:36Z","timestamp":1647426276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated Serum Regulator of Calcineurin 2 is Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Xia","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14078","DOI":"10.1074\/jbc.C110.107375","article-title":"Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARalpha-dependent Manner","volume":"285","author":"Adams","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/BJ20011797","article-title":"Novel Human ZAKI-4 Isoforms: Hormonal and Tissue-specific Regulation and Function as Calcineurin Inhibitors","volume":"367","author":"Cao","year":"2002","journal-title":"Biochem. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e3001522","DOI":"10.1371\/journal.pbio.3001522","article-title":"Rab2A Regulates the Progression of Nonalcoholic Fatty Liver Disease Downstream of AMPK-TBC1D1 axis by Stabilizing PPAR\u03b3","volume":"20","author":"Chen","year":"2022","journal-title":"Plos Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1096\/fj.06-7246com","article-title":"Renaming the DSCR1\/Adapt78 Gene Family as RCAN: Regulators of Calcineurin","volume":"21","author":"Davies","year":"2007","journal-title":"FASEB J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of Fatty Acids Stored in Liver and Secreted via Lipoproteins in Patients with Nonalcoholic Fatty Liver Disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","article-title":"Guidelines for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Update 2010: (Published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)","volume":"12","author":"Fan","year":"2011","journal-title":"J. Dig. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/hmg\/9.11.1681","article-title":"DSCR1, Overexpressed in Down Syndrome, Is an Inhibitor of Calcineurin-Mediated Signaling Pathways","volume":"9","author":"Fuentes","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/HYPERTENSIONAHA.118.12086","article-title":"Caloric Restriction Exacerbates Angiotensin II-Induced Abdominal Aortic Aneurysm in the Absence of P53","volume":"73","author":"Gao","year":"2019","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jss.2006.10.011","article-title":"Down Syndrome Candidate Region 1-like 1 (DSCR1-L1) Mimics the Inhibitory Effects of DSCR1 on Calcineurin Signaling in Endothelial Cells and Inhibits Angiogenesis","volume":"142","author":"Gollogly","year":"2007","journal-title":"J. Surg. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/his.13764","article-title":"Clinicopathological Significance of RCAN2 Production in Gastric Carcinoma","volume":"74","author":"Hattori","year":"2019","journal-title":"Histopathology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1101\/gad.14.13.1595","article-title":"A Conserved Family of Calcineurin Regulators","volume":"14","author":"Kingsbury","year":"2000","journal-title":"Genes Dev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.abb.2021.109047","article-title":"Long Non-coding RNA MALAT1 Silencing Elevates microRNA-26a-5p to Ameliorate Myocardial Injury in Sepsis by Reducing Regulator of Calcineurin 2","volume":"15","author":"Luo","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13062-021-00296-5","article-title":"NUAK2 and RCan2 Participate in the P53 Mutant Pro-tumorigenic Network","volume":"16","author":"Mammarella","year":"2021","journal-title":"Biol. Direct"},{"key":"B17","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1074\/jbc.271.24.14567","article-title":"Molecular Cloning of a Novel Thyroid Hormone-Responsive Gene, ZAKI-4, in Human Skin Fibroblasts","volume":"271","author":"Miyazaki","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1530\/eje.0.1500371","article-title":"Genomic Organization of Mouse ZAKI-4 Gene that Encodes ZAKI-4 Alpha and Beta Isoforms, Endogenous Calcineurin Inhibitors, and Changes in the Expression of These Isoforms by Thyroid Hormone in Adult Mouse Brain and Heart","volume":"150","author":"Mizuno","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/liv.14362","article-title":"Natural History of NASH and HCC","volume":"40","author":"Negro","year":"2020","journal-title":"Liver Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1038\/oncsis.2016.47","article-title":"KRAS Mutation Leads to Decreased Expression of Regulator of Calcineurin 2, Resulting in Tumor Proliferation in Colorectal Cancer","volume":"5","author":"Niitsu","year":"2016","journal-title":"Oncogenesis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of Nonalcoholic Steatohepatitis: An Overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8719","DOI":"10.1074\/jbc.275.12.8719","article-title":"A Protein Encoded within the Down Syndrome Critical Region Is Enriched in Striated Muscles and Inhibits Calcineurin Signaling","volume":"275","author":"Rothermel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1210\/endo.142.5.8156","article-title":"Expression of ZAKI-4 Messenger Ribonucleic Acid in the Brain during Rat Development and the Effect of Hypothyroidism","volume":"142","author":"Siddiq","year":"2001","journal-title":"Endocrinology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0378-1119(00)00407-8","article-title":"The Murine DSCR1-like (Down Syndrome Candidate Region 1) Gene Family: Conserved Synteny with the Human Orthologous Genes","volume":"257","author":"Strippoli","year":"2000","journal-title":"Gene"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e14605","DOI":"10.1371\/journal.pone.0014605","article-title":"Inactivation of the Rcan2 Gene in Mice Ameliorates the Age- and Diet-Induced Obesity by Causing a Reduction in Food Intake","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2100356","DOI":"10.1002\/mnfr.202100356","article-title":"The Association between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean General Population","volume":"65","author":"Tan","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.3390\/ijms22168646","article-title":"PPAR\u03b3-Induced Global H3K27 Acetylation Maintains Osteo\/Cementogenic Abilities of Periodontal Ligament Fibroblasts","volume":"22","author":"Yuan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1631\/jzus.B1600276","article-title":"A Disputed Evidence on Obesity: Comparison of the Effects of Rcan2(-\/-) and Rps6kb1(-\/-) Mutations on Growth and Body Weight in C57BL\/6J Mice","volume":"17","author":"Zhao","year":"2016","journal-title":"J. Zhejiang Univ. Sci. B"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.840764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T10:24:38Z","timestamp":1647426278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.840764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":29,"alternative-id":["10.3389\/fphar.2022.840764"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.840764","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"article-number":"840764"}}